{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:05:16Z","timestamp":1788973516543,"version":"build-2803163510"},"reference-count":74,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.bulcan.2024.05.010","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T11:38:44Z","timestamp":1725968324000},"page":"918-929","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The association between oral contraceptive pills and ovarian cancer risk: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"111","author":[{"given":"Maedeh","family":"Arshadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elahe","family":"Hesari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mozhgan","family":"Ahmadinezhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elahe Mansouri","family":"Yekta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fateme","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hosein","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahla Vaziri","family":"Esfarjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Rostami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzad","family":"Khodamoradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bulcan.2024.05.010_bib0375","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA: a cancer journal for clinicians"},{"issue":"1","key":"10.1016\/j.bulcan.2024.05.010_bib0380","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ygyno.2013.03.026","article-title":"An international assessment of ovarian cancer incidence and mortality","volume":"130","author":"Lowe","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2024.05.010_bib0385","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1186\/s12885-019-6139-6","article-title":"Global patterns and trends in ovarian cancer incidence: age, period and birth cohort analysis","volume":"19","author":"Zhang","year":"2019","journal-title":"BMC cancer"},{"issue":"1","key":"10.1016\/j.bulcan.2024.05.010_bib0390","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GRF.0b013e31824b4611","article-title":"Ovarian cancer: etiology, risk factors, and epidemiology","volume":"55","author":"Hunn","year":"2012","journal-title":"Clin Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.bulcan.2024.05.010_bib0395","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1369\/0022155411428469","article-title":"Breast and ovarian cancers: a survey and possible roles for the cell surface heparan sulfate proteoglycans","volume":"60","author":"Yoneda","year":"2012","journal-title":"J Histochem Cytochem: official journal of the Histochemistry Society"},{"key":"10.1016\/j.bulcan.2024.05.010_bib0400","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2147\/IJWH.S197604","article-title":"Ovarian cancer in the world: epidemiology and risk factors","volume":"11","author":"Momenimovahed","year":"2019","journal-title":"Int J Womens Health"},{"issue":"4","key":"10.1016\/j.bulcan.2024.05.010_bib0405","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1074\/mcp.R400006-MCP200","article-title":"Progress and challenges in screening for early detection of ovarian cancer","volume":"3","author":"Jacobs","year":"2004","journal-title":"Mol Cell Proteomics: MCP"},{"issue":"5\u20136","key":"10.1016\/j.bulcan.2024.05.010_bib0410","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1155\/2007\/309382","article-title":"Early detection of ovarian cancer","volume":"23","author":"Badgwell","year":"2007","journal-title":"Dis Markers"},{"issue":"12","key":"10.1016\/j.bulcan.2024.05.010_bib0415","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1007\/s10552-013-0296-8","article-title":"Oral contraceptive use and impact of cumulative intake of estrogen and progestin on risk of ovarian cancer","volume":"24","author":"Faber","year":"2013","journal-title":"Cancer Causes Control: CCC"},{"issue":"8","key":"10.1016\/j.bulcan.2024.05.010_bib0420","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1002\/ijc.29207","article-title":"Anthropometric factors and ovarian cancer risk: a systematic review and nonlinear dose-response meta-analysis of prospective studies","volume":"136","author":"Aune","year":"2015","journal-title":"Int J Can"},{"key":"10.1016\/j.bulcan.2024.05.010_bib0425","first-page":"359","article-title":"Obesity and gynaecological and obstetric conditions: umbrella review of the literature","author":"Kalliala","year":"2017","journal-title":"BMJ (Clinical research ed)"},{"issue":"4","key":"10.1016\/j.bulcan.2024.05.010_bib0430","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1080\/01635581.2018.1464346","article-title":"Usual Cruciferous Vegetable Consumption and Ovarian Cancer: A Case-Control Study","volume":"70","author":"McManus","year":"2018","journal-title":"Nutr Cancer"},{"issue":"9","key":"10.1016\/j.bulcan.2024.05.010_bib0435","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s10552-019-01198-8","article-title":"Dose\u2013risk relationships between cigarette smoking and ovarian cancer histotypes: a comprehensive meta-analysis","volume":"30","author":"Santucci","year":"2019","journal-title":"Cancer Causes Control"},{"issue":"9609","key":"10.1016\/j.bulcan.2024.05.010_bib0440","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","article-title":"Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls","volume":"371","author":"Beral","year":"2008","journal-title":"Lancet (London, England)"},{"issue":"6","key":"10.1016\/j.bulcan.2024.05.010_bib0445","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1158\/1055-9965.EPI-07-0089","article-title":"Different risk factor profiles for mucinous and nonmucinous ovarian cancer: results from the Danish MALOVA study","volume":"16","author":"Soegaard","year":"2007","journal-title":"Cancer Epidemiol Prev Biomarkers"},{"issue":"5","key":"10.1016\/j.bulcan.2024.05.010_bib0450","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/ijc.29471","article-title":"Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: Results from the EPIC cohort","volume":"137","author":"Fortner","year":"2015","journal-title":"Int J Can"},{"issue":"2","key":"10.1016\/j.bulcan.2024.05.010_bib0455","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/bjc.2016.400","article-title":"Combined oral contraceptive use before the first birth and epithelial ovarian cancer risk","volume":"116","author":"Cook","year":"2017","journal-title":"Br J Can"},{"key":"10.1016\/j.bulcan.2024.05.010_bib0460","doi-asserted-by":"crossref","first-page":"k3609","DOI":"10.1136\/bmj.k3609","article-title":"Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study","volume":"362","author":"Iversen","year":"2018","journal-title":"BMJ (Clinical research ed)"},{"issue":"9","key":"10.1016\/j.bulcan.2024.05.010_bib0465","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.annepidem.2016.07.004","article-title":"Reproductive factors and ovarian cancer risk in African-American women","volume":"26","author":"Moorman","year":"2016","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.bulcan.2024.05.010_bib0470","article-title":"Time-dependent effects of oral contraceptive use on breast, ovarian and endometrial cancers","author":"Karlsson","year":"2020","journal-title":"Can Res"},{"issue":"5","key":"10.1016\/j.bulcan.2024.05.010_bib0475","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.contraception.2012.02.019","article-title":"Reproductive factors in relation to ovarian cancer: a case-control study in Northern Vietnam","volume":"86","author":"Le","year":"2012","journal-title":"Contraception"},{"issue":"11","key":"10.1016\/j.bulcan.2024.05.010_bib0480","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s10552-018-1082-4","article-title":"Benign gynecologic conditions are associated with ovarian cancer risk in African-American women: a case\u2013control study","volume":"29","author":"Park","year":"2018","journal-title":"Cancer Causes Control"},{"issue":"3","key":"10.1016\/j.bulcan.2024.05.010_bib0485","doi-asserted-by":"crossref","first-page":"e1001182","DOI":"10.1371\/journal.pmed.1001182","article-title":"Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case-control study","volume":"9","author":"Urban","year":"2012","journal-title":"PLoS Med"},{"issue":"5","key":"10.1016\/j.bulcan.2024.05.010_bib0490","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10552-017-0876-0","article-title":"A prospective cohort study of oral contraceptive use and ovarian cancer among women in the United States born from 1947 to 1964","volume":"28","author":"Shafrir","year":"2017","journal-title":"Cancer Causes Control: CCC"},{"key":"10.1016\/j.bulcan.2024.05.010_bib0495","series-title":"The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","first-page":"1","author":"Peterson","year":"2011"},{"issue":"4","key":"10.1016\/j.bulcan.2024.05.010_bib0500","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/01.ede.0000164557.81694.63","article-title":"Mathematical models of ovarian cancer incidence","volume":"16","author":"Rosner","year":"2005","journal-title":"Epidemiology (Cambridge, Mass)"},{"issue":"3","key":"10.1016\/j.bulcan.2024.05.010_bib0505","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/sj.bjc.6603260","article-title":"Oral contraceptive use and cancer. Findings in a large cohort study, 1968-2004","volume":"95","author":"Vessey","year":"2006","journal-title":"Br J Can"},{"issue":"4","key":"10.1016\/j.bulcan.2024.05.010_bib0510","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/bjc.2013.803","article-title":"Oral contraceptive and reproductive risk factors for ovarian cancer within sisters in the breast cancer family registry","volume":"110","author":"Ferris","year":"2014","journal-title":"Br J Can"},{"issue":"5","key":"10.1016\/j.bulcan.2024.05.010_bib0515","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/ijc.29471","article-title":"Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: Results from the EPIC cohort","volume":"137","author":"Fortner","year":"2015","journal-title":"Int J Can"},{"issue":"7","key":"10.1016\/j.bulcan.2024.05.010_bib0520","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/aje\/kwg177","article-title":"Reproductive factors and epithelial ovarian cancer risk by histologic type: A multiethnic case-control study","volume":"158","author":"Tung","year":"2003","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.bulcan.2024.05.010_bib0525","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s10552-016-0840-4","article-title":"A prospective study of reproductive factors and exogenous hormone use in relation to ovarian cancer risk among Black women","volume":"28","author":"Bethea","year":"2017","journal-title":"Cancer Causes Control"},{"issue":"2","key":"10.1016\/j.bulcan.2024.05.010_bib0530","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ygyno.2009.06.040","article-title":"The epidemiology of ovarian granulosa cell tumors: A case-control study","volume":"115","author":"Boyce","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.bulcan.2024.05.010_bib0535","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1023\/A:1011128408146","article-title":"Reproductive and hormonal factors and ovarian cancer","volume":"12","author":"Chiaffarino","year":"2001","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.bulcan.2024.05.010_bib0540","first-page":"5229","article-title":"Central Adiposity as a Major Risk Factor of Ovarian Cancer","volume":"29","author":"Delort","year":"2009","journal-title":"Antican Res"},{"issue":"3","key":"10.1016\/j.bulcan.2024.05.010_bib0545","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/ijc.32322","article-title":"The influence of birth cohort and calendar period on global trends in ovarian cancer incidence","volume":"146","author":"Cabasag","year":"2020","journal-title":"Int J Can"},{"issue":"12","key":"10.1016\/j.bulcan.2024.05.010_bib0550","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1002\/ijc.33493","article-title":"First-and second-degree family history of ovarian and breast cancer in relation to risk of invasive ovarian cancer in African American and white women","volume":"148","author":"Bethea","year":"2021","journal-title":"Int J Can"},{"issue":"3","key":"10.1016\/j.bulcan.2024.05.010_bib0555","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/jnci\/djaa099","article-title":"Expanding our understanding of ovarian cancer risk: the role of incomplete pregnancies","volume":"113","author":"Lee","year":"2021","journal-title":"JNCI: J Natl Can Inst"},{"issue":"3","key":"10.1016\/j.bulcan.2024.05.010_bib0560","first-page":"78","article-title":"Oral contraceptives use reduces ovarian and endometrial cancer risk","volume":"16","author":"Cioroba","year":"2021","journal-title":"Rom J Med Pract"},{"issue":"6","key":"10.1016\/j.bulcan.2024.05.010_bib0565","doi-asserted-by":"crossref","first-page":"e200421","DOI":"10.1001\/jamaoncol.2020.0421","article-title":"Association between breastfeeding and ovarian cancer risk","volume":"6","author":"Babic","year":"2020","journal-title":"JAMA oncology"},{"issue":"5","key":"10.1016\/j.bulcan.2024.05.010_bib0570","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/cncr.22082","article-title":"Family history of breast cancer as a risk factor for ovarian cancer in a prospective study","volume":"107","author":"Kazerouni","year":"2006","journal-title":"Cancer: Interdisciplinary International Journal of the American Cancer Society"},{"issue":"4","key":"10.1016\/j.bulcan.2024.05.010_bib0575","first-page":"708","article-title":"A quantitative assessment of oral contraceptive use and risk of ovarian cancer","volume":"80","author":"Hankinson","year":"1992","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.bulcan.2024.05.010_bib0580","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s004320000153","article-title":"Epidemiological and molecular aspects of ovarian cancer risk","volume":"127","author":"Runnebaum","year":"2001","journal-title":"J Can Res Clin Oncol"},{"issue":"4","key":"10.1016\/j.bulcan.2024.05.010_bib0585","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/bjc.1989.320","article-title":"Risk factors for ovarian cancer: a case-control study","volume":"60","author":"Booth","year":"1989","journal-title":"Br J Can"},{"issue":"1","key":"10.1016\/j.bulcan.2024.05.010_bib0590","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GRF.0b013e31824b4611","article-title":"Ovarian cancer: etiology, risk factors, and epidemiology","volume":"55","author":"Hunn","year":"2012","journal-title":"Clin Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.bulcan.2024.05.010_bib0595","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJM199808133390702","article-title":"Oral contraceptives and the risk of hereditary ovarian cancer","volume":"339","author":"Narod","year":"1998","journal-title":"New Engl J Med"},{"issue":"17","key":"10.1016\/j.bulcan.2024.05.010_bib0600","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1056\/NEJM198210213071703","article-title":"Factors affecting the association of oral contraceptives and ovarian cancer","volume":"307","author":"Cramer","year":"1982","journal-title":"New Engl J Med"},{"issue":"6","key":"10.1016\/j.bulcan.2024.05.010_bib0605","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/bjc.1995.260","article-title":"Endometrial and ovarian cancer and oral contraceptives-findings in a large cohort study","volume":"71","author":"Vessey","year":"1995","journal-title":"Br J Can"},{"issue":"1","key":"10.1016\/j.bulcan.2024.05.010_bib0610","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/AOG.0b013e318291c235","article-title":"Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis","volume":"122","author":"Havrilesky","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.bulcan.2024.05.010_bib0615","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/aje\/152.3.233","article-title":"Risk of ovarian cancer in relation to estrogen and progestin dose and use characteristics of oral contraceptives","volume":"152","author":"Ness","year":"2000","journal-title":"Am J Epidemiol"},{"issue":"23","key":"10.1016\/j.bulcan.2024.05.010_bib0620","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1093\/jnci\/90.23.1774","article-title":"Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone","volume":"90","author":"Risch","year":"1998","journal-title":"J Natl Can Inst"},{"issue":"1\u20132","key":"10.1016\/j.bulcan.2024.05.010_bib0625","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mce.2005.09.014","article-title":"Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses","volume":"247","author":"Fleming","year":"2006","journal-title":"Mol Cell Endocrinol"},{"issue":"11","key":"10.1016\/j.bulcan.2024.05.010_bib0630","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1056\/NEJM198703123161102","article-title":"The reduction in risk of ovarian cancer associated with oral-contraceptive use","volume":"316","year":"1987","journal-title":"New Engl J Med"},{"issue":"4","key":"10.1016\/j.bulcan.2024.05.010_bib0635","first-page":"292","article-title":"Incessant ovulation and ovarian cancer\u2013a hypothesis re-visited","volume":"5","author":"Fathalla","year":"2013","journal-title":"Facts, views & vision in ObGyn"},{"issue":"9","key":"10.1016\/j.bulcan.2024.05.010_bib0640","doi-asserted-by":"crossref","first-page":"397","DOI":"10.12775\/JEHS.2020.10.09.046","article-title":"Risk factors of ovarian cancer: family history, obesity and oral contraceptive use","volume":"10","author":"Kuchnicka","year":"2020","journal-title":"J Educ Health Sport"},{"issue":"3","key":"10.1016\/j.bulcan.2024.05.010_bib0645","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ygyno.2017.01.002","article-title":"Parity, infertility, oral contraceptives, and hormone replacement therapy and the risk of ovarian serous borderline tumors: A nationwide case-control study","volume":"144","author":"Rasmussen","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"9609","key":"10.1016\/j.bulcan.2024.05.010_bib0650","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","article-title":"Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23 257 women with ovarian cancer and 87 303 controls","volume":"371","year":"2008","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.bulcan.2024.05.010_bib0655","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/ijc.10696","article-title":"Long-term effects of oral contraceptives on ovarian cancer risk","volume":"102","author":"Bosetti","year":"2002","journal-title":"Int J Can"},{"issue":"7","key":"10.1016\/j.bulcan.2024.05.010_bib0660","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/oxfordjournals.aje.a117055","article-title":"A case-control study of oral contraceptive use and invasive epithelial ovarian cancer","volume":"139","author":"Rosenberg","year":"1994","journal-title":"Am J Epidemiol"},{"issue":"10","key":"10.1016\/j.bulcan.2024.05.010_bib0665","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/oxfordjournals.aje.a116427","article-title":"Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies: II. Invasive epithelial ovarian cancers in white women","volume":"136","author":"Whittmore","year":"1992","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.bulcan.2024.05.010_bib0670","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/aje\/kwf048","article-title":"Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study","volume":"156","author":"Riman","year":"2002","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.bulcan.2024.05.010_bib0675","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/ije\/20.4.871","article-title":"Risk factors for epithelial ovarian tumours of borderline malignancy","volume":"20","author":"Parazzini","year":"1991","journal-title":"Int J Epidemiol"},{"issue":"3","key":"10.1016\/j.bulcan.2024.05.010_bib0680","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.gofs.2020.01.012","article-title":"Borderline ovarian tumours: CNGOF guidelines for clinical practice-epidemiological aspects and risk factors","volume":"48","author":"Ouldamer","year":"2020","journal-title":"Gynecologie, Obstetrique, Fertilite & Senologie"},{"issue":"20","key":"10.1016\/j.bulcan.2024.05.010_bib0685","first-page":"5849","article-title":"Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormones","volume":"48","author":"Harlow","year":"1988","journal-title":"Can Res"},{"issue":"2","key":"10.1016\/j.bulcan.2024.05.010_bib0690","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/01443615.2018.1499076","article-title":"Clinicopathological analysis of borderline ovarian tumours and risk factors related to recurrence: experience of single institution","volume":"39","author":"Sozen","year":"2019","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.bulcan.2024.05.010_bib0695","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13048-021-00911-z","article-title":"Investigation on factors associated with ovarian cancer: An umbrella review of systematic review and meta-analyses","volume":"14","author":"Tanha","year":"2021","journal-title":"J Ovarian Res"},{"issue":"6","key":"10.1016\/j.bulcan.2024.05.010_bib0700","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/1097-0215(20011120)95:6<370::AID-IJC1065>3.0.CO;2-T","article-title":"Low-dose oral contraceptives: Protective effect on ovarian cancer risk","volume":"95","author":"Royar","year":"2001","journal-title":"Int J Can"},{"issue":"8","key":"10.1016\/j.bulcan.2024.05.010_bib0705","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/ijc.23724","article-title":"Borderline ovarian tumors in Sweden 1960-2005: trends in incidence and age at diagnosis compared to ovarian cancer","volume":"123","author":"Sk\u00edrnisd\u00f3ttir","year":"2008","journal-title":"Int J Can"},{"key":"10.1016\/j.bulcan.2024.05.010_bib0710","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/978-981-13-3438-2_17","article-title":"Epidemiology and risk factors for ovarian cancer","author":"Singla","year":"2019","journal-title":"Preventive Oncology for the Gynecologist"},{"issue":"1","key":"10.1016\/j.bulcan.2024.05.010_bib0715","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/medicines5010016","article-title":"Ovarian cancers: genetic abnormalities, tumor heterogeneity and progression, clonal evolution and cancer stem cells","volume":"5","author":"Testa","year":"2018","journal-title":"Medicines"},{"key":"10.1016\/j.bulcan.2024.05.010_bib0720","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2147\/IJWH.S197604","article-title":"Ovarian cancer in the world: epidemiology and risk factors","author":"Momenimovahed","year":"2019","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.bulcan.2024.05.010_bib0725","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2165\/00002018-200124100-00003","article-title":"Oral contraceptives and cancer: an update","volume":"24","author":"La Vecchia","year":"2001","journal-title":"Drug Saf"},{"issue":"4","key":"10.1016\/j.bulcan.2024.05.010_bib0730","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/01.AOG.0000154152.12088.48","article-title":"Androgenic progestins in oral contraceptives and the risk of epithelial ovarian cancer","volume":"105","author":"Greer","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.bulcan.2024.05.010_bib0735","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/jnci\/94.1.32","article-title":"Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk","volume":"94","author":"Schildkraut","year":"2002","journal-title":"J Natl Can Inst"},{"key":"10.1016\/j.bulcan.2024.05.010_bib0740","first-page":"362","article-title":"Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study","author":"Iversen","year":"2018","journal-title":"BMJ"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000745512400256X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000745512400256X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T21:05:34Z","timestamp":1727125534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000745512400256X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":74,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S000745512400256X"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2024.05.010","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association between oral contraceptive pills and ovarian cancer risk: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2024.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}